Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P. -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (1384)	2/18/2000 1:48:00 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 4974

Friday February 18, 12:08 pm Eastern Time Company Press Release SOURCE: Avigen, Inc. Avigen, Inc. Files Registration Statement in Public Offering of Common Stock ALAMEDA, Calif., Feb. 18 /PRNewswire/ -- Avigen, Inc. (Nasdaq: AVGN - news) today announced it has filed a registration statement in connection with a proposed underwritten public offering of 4,000,000 shares of its Common Stock, plus an over-allotment option of 600,000 shares, all of which are being offered by Avigen. Salomon Smith Barney Inc., CIBC World Markets Corp. and ING Barings LLC are managers of the underwriting syndicate, which will offer the shares to the public. (snip)